A Swedish study has found a new potential therapeutic target for diabetes. Inhibition of a protein named MNK2 regenerated pancreatic insulin-producing cells in zebrafish larvae, laboratory pigs, and human cell cultures.
“Our findings indicate a new potential target for treating diabetes, in that we demonstrate a possible way of stimulating the formation of new insulin-producing cells,” said Dr. Olov Andersson, senior researcher at the Department of Cell and Molecular Biology at Karolinska Institute.
